Day: March 7, 2022

I fortsættelse af tidligere meddelelse d. 7/3 2022 skal det herved oplyses, at det nu igen er muligt at stille indre værdier i nedenstående fonde, hvorfor Nykredit Portefølje Administration A/S har anmodet Nasdaq Copenhagen A/S om, at suspension ophæves. Ophævelsen gælder følgende fonde:ISIN  Afdelingsnavn Orderbook codeDK0016188733 Nykredit Invest Balance Defensiv NBIDEDK0016188816 Nykredit Invest Balance Moderat NBIMODK0060441749 Nykredit Invest Balance Offensiv NBIOFEventuelle spørgsmål vedrørende denne meddelelse kan rettes til npa.pm@nykredit.dk eller JNA@nykredit.dk Med venlig hilsen Nykredit Portefølje Administration A/S Tage Fabrin-Brasted

ANNOUNCEMENT NO. 59 – 7 MARCH 2022 Under Article 19 of the Market Abuse Regulation Dampskibsselskabet NORDEN A/S is required to report transactions in Dampskibsselskabet NORDEN A/S’ shares by persons discharging managerial responsibilities and their close relatives.Name:   Benedicte Hedengran WegenerReason:   Reporting duty, employee-elected board memberIssuer:   Dampskibsselskabet NORDEN A/SISIN code:   DK0010269844Instrument:   SharesTransaction:   Sale of sharesTrading date:   4 March 2022Market:   Nasdaq CopenhagenNumber:   4,000Market value in DKK:   874,880Holding after transaction   1,761Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tel.: 3315 0451AttachmentNo. 59 Related party transactions ...

TLC599 reduces pain and improves function for up to 24 weeks, longer than existing intraarticular treatments, and significantly reduces oral medication use SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, March 07, 2022 (GLOBE NEWSWIRE) — TLC BioSciences, a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced that detailed results of its TLC599 Phase 2 clinical trial in patients with osteoarthritis of the knee have been published in the peer-reviewed journal Arthritis Research & Therapy. TLC599 is a proprietary BioSeizer® sustained release formulation of dexamethasone sodium phosphate (DSP) intended for the treatment of osteoarthritis pain. The results demonstrated statistically significantly reduced pain scores and oral pain medication use for...

As mentioned in Announcement no. 03/2022 Coloplast is initiating a share buyback programme totalling up to DKK 500 million.The programme commenced on 21 February 2022 and will end no later than 19 August 2022. The share buyback programme is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulations with the purpose of meeting obligations arising from share options programmes or other allocation of shares to employees or to complete a share capital decrease as set out in Articles 5(2)(a) and 5(2)(c) in MAR. The following transactions have been executed during the period 28 February – 4 March 2022:Date Number of shares Average purchase price, DKK Transaction value,...

Oslo, 7 March 2022: Scatec ASA has today signed an agreement with ACME Group from India to establish a 50/50 joint venture to design, develop, build, own and operate a large-scale green ammonia facility in Oman. The first phase of the facility is expected to produce 100,000 tonnes of green ammonia annually with about 300 MW of electrolyzer capacity and powered by 500 MW of solar. The facility will be located in the Duqm Special Economic Zone of Oman. Once fully developed the facility is expected to produce up to 1.2 million tonnes of green ammonia annually. “Oman has excellent solar resources and a strategic location for production of green ammonia. Acme Group has been in the forefront of green ammonia production with this project, and in Scatec we can capitalise on our expertise in renewables, project structuring and financing, execution...

Update on Crédit Agricole S.A.’s financial situation in Ukraine and Russia In the current situation, of war in Ukraine and crisis with Russia, Crédit Agricole Group wishes to be transparent regarding its exposure to these two countries. The activities of the Group in Ukraine and Russia are locally operated through two 100% owned subsidiaries: the international retail bank Crédit Agricole Ukraine and the subsidiary of Crédit Agricole CIB in Russia, CACIB AO. In 2021, the activities of CA Ukraine and Crédit Agricole CIB AO represented the following contributions:Country Net banking income excluding intragroup eliminations(in millions of euros) Average headcount   (in FTE) Earnings before tax   (in millions of euros)Ukraine 125 2,286 58Russia 22 168 5The total exposure (on-shore and off-shore) of Crédit Agricole S.A. in these...